Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...

healthcare.philips.com
from healthcare.philips.com More from this publisher
19.02.2013 Views

CMS-1403-FC 1000 methodology specified in sections 1833(o) and 1834(h) of the Act. Section 627 of the MMA amended section 1833(o)(2) of the Act to require implementation of fee schedule amounts, effective January 1, 2005, for the purpose of determining payment for custom molded shoes, extra-depth shoes, and inserts (collectively, “therapeutic shoes”). Section 627 of the MMA was initially implemented through program instructions, and on January 1, 2005, Medicare began paying for therapeutic shoes, inserts, and shoe modifications based on fee schedule amounts determined in accordance with section 1834(h) of the Act and 42 CFR part 414, subpart D of our regulations. We did not receive any comments on our proposal to add §414.228(c) to 42 CFR part 414, subpart D of our regulations. Therefore, we are finalizing proposed §414.228(c) regarding the methodology used to establish fee schedule amounts for therapeutic shoes, inserts and shoe modifications.

CMS-1403-FC XII. Provisions of the Final Rule The provisions of this final rule with comment period restate the provisions of the CY 2009 PFS proposed rule, except as noted elsewhere in the preamble. XIII. Waiver of Proposed Rulemaking and Delay in Effective Date We ordinarily publish a notice of proposed rulemaking in the Federal Register and invite public comment on the proposed rule. The notice of proposed rulemaking includes a reference to the legal authority under which the rule is proposed, and the terms and substances of the proposed rule or a description of the subjects and issues involved. This procedure can be waived, however, if an agency finds good cause that a notice-and-comment procedure is impracticable, unnecessary, or contrary to the public interest and incorporates a statement of the finding and its reasons in the rule issued. We utilize HCPCS codes for Medicare payment purposes. The HCPCS is a national drug coding system comprised of Level I (CPT) codes and Level II (HCPCS National Codes) that are intended to provide uniformity to coding procedures, services, and supplies across all types of medical providers and suppliers. Level I (CPT) codes are copyrighted by the AMA and consist of several categories, 1001

<strong>CMS</strong>-1403-FC<br />

XII. Provisions of the Final Rule<br />

The provisions of this final rule with comment period<br />

restate the provisions of the CY 2009 PFS proposed rule,<br />

except as noted elsewhere in the preamble.<br />

XIII. Waiver of Proposed Rulemaking and Delay in Effective<br />

Date<br />

We ordinarily publish a notice of proposed rulemaking<br />

in the Federal Register and invite public comment on the<br />

proposed rule. The notice of proposed rulemaking includes<br />

a reference to the legal authority under which the rule is<br />

proposed, and the terms and substances of the proposed rule<br />

or a description of the subjects and issues involved. <strong>This</strong><br />

procedure can be waived, however, if an agency finds good<br />

cause that a notice-and-comment procedure is impracticable,<br />

unnecessary, or contrary to the public interest and<br />

incorporates a statement of the finding and its reasons in<br />

the rule issued.<br />

We utilize HCPCS codes for Medicare payment purposes.<br />

The HCPCS is a national drug coding system comprised of<br />

Level I (CPT) codes and Level II (HCPCS National Codes)<br />

that are intended to provide uniformity to coding<br />

procedures, services, and supplies across all types of<br />

medical providers and suppliers. Level I (CPT) codes are<br />

copyrighted by the AMA and consist of several categories,<br />

1001

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!